Variability of treatment duration for bacteraemia in the critically ill: A multinational survey.
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: No definitive evidence is available to inform 'best' antibiotic practice for treating bacteraemia in the critically ill patient, either in terms of duration of therapy, or the use of mono- versus combination therapy. We therefore undertook a large-scale international survey to assess the variability of current practice. METHODS: A questionnaire was sent to membership lists of national and international intensive care societies. RESULTS: Responses from 254 intensive care units in 34 countries revealed a wide variation in antibiotic strategy for all types of bacteraemia, ranging from short course ( or=10 days) use of broad-spectrum combinations. Two factors were significantly associated with antibiotic prescribing practice, namely the country of origin (in those with >or=10 responders) and the level of microbiologist and/or infectious diseases specialist input. The greater the specialist input, the shorter the duration of therapy (P < 0.0001). CONCLUSIONS: The wide variability in antibiotic prescribing patterns suggests an urgent need to produce high-quality evidence to identify optimal antibiotic prescribing policies for bacteraemia in the critically ill patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While there appears to be no overall effect of neuraminidase inhibitors on mortality in patients with influenza-related pneumonia, there may be an effect when administered early in the course of the disease (225).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [225]
In the citing paper
“Given the lack of definitive and generalizable data regarding the optimal duration of therapy for patients who are critically ill, it is not surprising that there is considerably practice variation [281, 294].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [294]
Citations
Cites
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
A 25-year study of nosocomial bacteremia in an adult intensive care unit
Edgeworth, J. D., Treacher, D. F., & Eykyn, S. J. (1999) · Critical Care Medicine · doi:10.1097/00003246-199908000-00002 · Cited by 178
Early and late onset bacteremia have different risk factors in trauma patients
Antonelli, M. M., Moro, M. L., D’Errico, R. R., Conti, G., Bufi, M., & GASPARETTO, A. (1996) · Intensive Care Medicine · doi:10.1007/bf01709514 · Cited by 27
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis
Havey, T. C., Fowler, R. A., & Daneman, N. (2011) · Critical Care · doi:10.1186/cc10545 · Cited by 187
“In the absence of high-grade evidence, there is wide variability in antibiotic treatment duration recommendations from infectious disease and critical care specialists, and the presence of bacteremia is often used as a justification for extended courses of antibiotic therapy regardless of the observed clinical respons…”
BackgroundChotiprasitsakul, D., Han, J. H., Cosgrove, S. E., Harris, A. D., Lautenbach, E., Conley, A. T., Tolomeo, P., Wise, J., Tamma, P. D., & Antibacterial Resistance Leadership Group (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix767 · Cited by 173
“A 2001 multinational survey revealed that the durations of antibiotic therapy prescribed for gram-negative bacteremia range widely among clinicians [13].”
BackgroundEliakim-Raz, N., Yahav, D., Paul, M., & Leibovici, L. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt177 · Cited by 153
Metadata
- Authors
- Corona, A.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Corresponding author
- Corona, A.
- ORCID
- Corona, A.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09-30
- Volume
- 52
- Issue
- 5
- Pages
- 849-852
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2107284057
- Semantic Scholar
- c71bbf7070eac513daa94bfeed961940b49cd5e4
- Cited by
- 43
- References
- 3
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 3 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 4
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- Gilead Sciences
- Intensive Care Society
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- bacteremia, critically ill patients, antibiotic duration, antibiotic prescribing, combination antibiotic therapy, broad-spectrum antibiotics, intensive care unit, international variation in practice
- MeSH terms
- Anti-Bacterial Agents, Drug Therapy, Combination, Humans, Intensive Care Units, Surveys and Questionnaires, Societies, Medical, Time Factors, Bacteremia, Critical Illness, Health Care Surveys, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Variability of treatment duration for bacteraemia in the critically ill: A multinational survey. https://app.cochat.ai/papers/10.1093/jac/dkg447
- The paper
- Corona, A. (2003). Variability of treatment duration for bacteraemia in the critically ill: A multinational survey. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkg447
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.